NOV 03, 2016 6:00 AM PDT

IQCP is a four letter word

Speaker
  • Assistant Professor Pathology, Director of Chemistry, Immunology, Toxicology, and Point of Care; Ohio State University Wexner Medical Center
    Biography
      Dr. Cotten is Director for Chemistry, Immunology, Toxicology and Point-of-Care testing at the Ohio State University Wexner Medical Center and Assistant Professor in Pathology at the Ohio State University. He received his PhD in Pharmaceutical Sciences from the School of Pharmacy at the University of North Carolina at Chapel Hill where he also completed his training in clinical chemistry in the Department of Pathology. Dr. Cotten is board certified in Clinical Chemistry by the American Board of Clinical Chemistry. He has served as the chair of the AACC Ohio Valley Local Section and is currently the newsletter editor and online community moderator for the new Mass Spectrometry and Separation Sciences (MS3) Division of The American Association for Clinical Chemistry. His primary research interests include drug testing in alternative matrices and operational efficiency metrics for clinical laboratories.

    Abstract

    IQCP represents a new approach to quality control for clinical laboratories.  Beginning in 2016 clinical laboratories were tasked with developing individualized quality control plans for a variety of testing platforms.  This session will review the fundamentals of IQCP and how laboratories can handle implementing individualized quality control in their labs. Guidelines from CMS and CAP will be compared in regards to documentation and expectations for each accrediting organization.  Additional methods to audit the effectiveness of a labs IQCP will be explored.

    After attending this session participants should be able to:
    1. Define the components of an IQCP
    2. Develop an IQCP for a laboratory test
    3. Identify the differences between CMS and CAP documentation for IQCPs


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    JUN 09, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    C.E. CREDITS
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    Loading Comments...
    Show Resources
    Attendees
    • See more